MedTrace Logo

Efficacy and Safety of b-2Cool on Adults With Joint Discomfort

NCT02843620 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-07-20

No results posted yet for this study

Summary

This study evaluates the effects of 40 mg of b-2Cool, a food supplement rich in native type-II collagen, on healthy adults with joint discomfort. Half of the participants will receive the b-2Cool containing supplement while the other half will receive a placebo pill.

Conditions

  • Joint Discomfort

Interventions

DIETARY_SUPPLEMENT

b-2Cool

b-2Cool® is native type II collagen extracted from chicken sternums

OTHER

Placebo

Excipients only

Sponsors & Collaborators

  • Bioiberica

    lead INDUSTRY

Principal Investigators

  • Ingrid Möller, Dr. · Instituto Poal de Reumatología

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2018-07-31
Completion
2018-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02843620 on ClinicalTrials.gov